DT-7012
N/A
Report date: 2026/05/07 20:00:36
Base Information
Drug NameDT-7012
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDomain Therapeutics SA
China Registration ClassN/A
Develop Information
Active CompaniesDomain Therapeutics Australia Pty LtdDomain Therapeutics SAXikang (Wuhan) Biomedicine Co Ltd
Inactive CompaniesN/A
Active Indications +[4]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A